Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Laure Plissonnier

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis BMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Journal of Hepatology|December 11, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis deltaElisabetta Degasperi, Caroline Scholtes, Barbara Testoni, et al.
Hepatology (Baltimore, Md.)|March 7, 2022
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translationRomain Barnault, Claire Verzeroli, Carole Fournier, et al.
Journal of Hepatology|June 6, 2026
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis BCamilla Ceccatelli Berti, Ilaria Montali, Sara Doselli, et al.
Gut|May 2, 2024
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanismArmando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, et al.
JHEP Reports : Innovation in Hepatology|September 18, 2024
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBxMarc Ringelhan, Svenja Schuehle, Maarten van de Klundert, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2024
Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptorsCharlotte A Hernandez, Claire Verzeroli, Armando Andres Roca-Suarez, et al.
Alimentary Pharmacology & Therapeutics|November 20, 2025
Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue CessationArno Furquim d'Almeida, Axelle Vanderlinden, Stefan Bourgeois, et al.
Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Journal of Hepatology|February 29, 2024
Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunityBalakrishnan Chakrapani Narmada, Atefeh Khakpoor, Niranjan Shirgaonkar, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis BMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Journal of Hepatology|December 11, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis deltaElisabetta Degasperi, Caroline Scholtes, Barbara Testoni, et al.
Hepatology (Baltimore, Md.)|March 7, 2022
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translationRomain Barnault, Claire Verzeroli, Carole Fournier, et al.
Journal of Hepatology|June 6, 2026
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis BCamilla Ceccatelli Berti, Ilaria Montali, Sara Doselli, et al.
Gut|May 2, 2024
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanismArmando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, et al.
JHEP Reports : Innovation in Hepatology|September 18, 2024
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBxMarc Ringelhan, Svenja Schuehle, Maarten van de Klundert, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2024
Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptorsCharlotte A Hernandez, Claire Verzeroli, Armando Andres Roca-Suarez, et al.
Alimentary Pharmacology & Therapeutics|November 20, 2025
Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue CessationArno Furquim d'Almeida, Axelle Vanderlinden, Stefan Bourgeois, et al.
Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Journal of Hepatology|February 29, 2024
Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunityBalakrishnan Chakrapani Narmada, Atefeh Khakpoor, Niranjan Shirgaonkar, et al.
Pageof 4